Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses

Samankaltaisia teoksia

• Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial
  Tekijä: Soares, Marta O, et al.
  Julkaistu: (2014)
• An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis
  Tekijä: MO Soares, et al.
  Julkaistu: (2012-02-01)
• An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.
  Tekijä: Soares, M O, et al.
  Julkaistu: (2012)
• External validity of rct evidence in cost-effectiveness analyses. A review of recent technology appraisals for nice and proposed methods of adjustment
  Tekijä: Mantopoulos, Theodoros, et al.
  Julkaistu: (2015)
• Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses
  Tekijä: Colbourn, Tim E, et al.
  Julkaistu: (2007)